In addition, TFE3-KD also decreased GFP-LC3 puncta number and inhibited GFP-LC3 degradation in RCC cell stably expressing GFP-LC3 (Figs. 6, F and G and S6D). This evidence concerns the gene MAP1LC3A and renal cell carcinoma.